STOCK TITAN

Esperion to Participate in Upcoming Virtual Cowen 42nd Annual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Esperion (NASDAQ: ESPR) will have its Chief Medical Officer, Dr. JoAnne Foody, participate in a Cardiometabolic/NASH panel at the Cowen 42nd Annual Healthcare Conference on March 8, 2022. This event will include one-on-one investor meetings and will be held in a virtual format starting at 12:50 p.m. ET. Live webcasts will be available on the company's investor relations website, with replays archived for 90 days post-event. Esperion focuses on lipid management and aims to provide innovative treatments for cholesterol reduction.

Positive
  • None.
Negative
  • None.

ANN ARBOR, Mich., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that Chief Medical Officer, Dr. JoAnne Foody, will participate in a Cardiometabolic/NASH focused panel, in addition to one-on-one investor meetings with other members of management, at the upcoming Cowen 42nd Annual Healthcare Conference on Tuesday, March 8, 2022.

Event:Cowen 42nd Annual Healthcare Conference
Date:Tuesday, March 8, 2022
Format:Virtual Panel and 1:1 Meetings
Panel:Cardiometabolic/NASH
Time:12:50 p.m. ET

Live audio webcasts of these events can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replays of the webcasts will be archived on the Company's website for 90 days following the events.

Esperion Therapeutics

Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Investor Contact:
Kaitlyn Brosco
Esperion
corporateteam@esperion.com 


FAQ

What is the date of the Cowen 42nd Annual Healthcare Conference for Esperion?

The Cowen 42nd Annual Healthcare Conference will take place on March 8, 2022.

Who will represent Esperion at the Cowen Healthcare Conference?

Dr. JoAnne Foody, the Chief Medical Officer, will represent Esperion.

What topic will be discussed at the panel involving Esperion?

The panel will focus on Cardiometabolic/NASH.

What time will Esperion's panel start at the conference?

The panel is scheduled to start at 12:50 p.m. ET.

Where can I access the live webcasts for Esperion's event?

Live audio webcasts can be accessed on the investor relations section of Esperion's website.

Esperion Therapeutics, Inc.

NASDAQ:ESPR

ESPR Rankings

ESPR Latest News

ESPR Stock Data

476.49M
196.07M
0.5%
66.33%
17.05%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR